BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12621456)

  • 21. Tet-On Systems For Doxycycline-inducible Gene Expression.
    Das AT; Tenenbaum L; Berkhout B
    Curr Gene Ther; 2016; 16(3):156-67. PubMed ID: 27216914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in Gene Therapy for Diseases of the Eye.
    Petit L; Khanna H; Punzo C
    Hum Gene Ther; 2016 Aug; 27(8):563-79. PubMed ID: 27178388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained Neural Stem Cell-Based Intraocular Delivery of CNTF Attenuates Photoreceptor Loss in the nclf Mouse Model of Neuronal Ceroid Lipofuscinosis.
    Jankowiak W; Kruszewski K; Flachsbarth K; Skevas C; Richard G; Rüther K; Braulke T; Bartsch U
    PLoS One; 2015; 10(5):e0127204. PubMed ID: 25992714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CNTF Gene Therapy Confers Lifelong Neuroprotection in a Mouse Model of Human Retinitis Pigmentosa.
    Lipinski DM; Barnard AR; Singh MS; Martin C; Lee EJ; Davies WIL; MacLaren RE
    Mol Ther; 2015 Aug; 23(8):1308-1319. PubMed ID: 25896245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances of stem cell therapy for retinitis pigmentosa.
    He Y; Zhang Y; Liu X; Ghazaryan E; Li Y; Xie J; Su G
    Int J Mol Sci; 2014 Aug; 15(8):14456-74. PubMed ID: 25141102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CNTF-mediated protection of photoreceptors requires initial activation of the cytokine receptor gp130 in Müller glial cells.
    Rhee KD; Nusinowitz S; Chao K; Yu F; Bok D; Yang XJ
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):E4520-9. PubMed ID: 24191003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetically modified neural stem cells for a local and sustained delivery of neuroprotective factors to the dystrophic mouse retina.
    Jung G; Sun J; Petrowitz B; Riecken K; Kruszewski K; Jankowiak W; Kunst F; Skevas C; Richard G; Fehse B; Bartsch U
    Stem Cells Transl Med; 2013 Dec; 2(12):1001-10. PubMed ID: 24167317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene therapy for retinal disease.
    McClements ME; MacLaren RE
    Transl Res; 2013 Apr; 161(4):241-54. PubMed ID: 23305707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene therapy in animal models of autosomal dominant retinitis pigmentosa.
    Rossmiller B; Mao H; Lewin AS
    Mol Vis; 2012; 18():2479-96. PubMed ID: 23077406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients.
    Colella P; Auricchio A
    Hum Gene Ther; 2012 Aug; 23(8):796-807. PubMed ID: 22734691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging gene therapies for retinal degenerations.
    Cepko CL
    J Neurosci; 2012 May; 32(19):6415-20. PubMed ID: 22573664
    [No Abstract]   [Full Text] [Related]  

  • 32. Manipulation of the recipient retinal environment by ectopic expression of neurotrophic growth factors can improve transplanted photoreceptor integration and survival.
    West EL; Pearson RA; Duran Y; Gonzalez-Cordero A; MacLaren RE; Smith AJ; Sowden JC; Ali RR
    Cell Transplant; 2012; 21(5):871-87. PubMed ID: 22325046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CNTF and retina.
    Wen R; Tao W; Li Y; Sieving PA
    Prog Retin Eye Res; 2012 Mar; 31(2):136-51. PubMed ID: 22182585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of daylight vision in retinal degeneration: are oxidative stress and metabolic dysregulation to blame?
    Punzo C; Xiong W; Cepko CL
    J Biol Chem; 2012 Jan; 287(3):1642-8. PubMed ID: 22074929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C1q enhances cone photoreceptor survival in a mouse model of autosomal recessive retinitis pigmentosa.
    Humphries MM; Kenna PF; Campbell M; Tam LC; Nguyen AT; Farrar GJ; Botto M; Kiang AS; Humphries P
    Eur J Hum Genet; 2012 Jan; 20(1):64-8. PubMed ID: 21863053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Republished review: Gene therapy for ocular diseases.
    Liu MM; Tuo J; Chan CC
    Postgrad Med J; 2011 Jul; 87(1029):487-95. PubMed ID: 21705775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ciliary neurotrophic factor induces genes associated with inflammation and gliosis in the retina: a gene profiling study of flow-sorted, Müller cells.
    Xue W; Cojocaru RI; Dudley VJ; Brooks M; Swaroop A; Sarthy VP
    PLoS One; 2011; 6(5):e20326. PubMed ID: 21637858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of calcium ion, calpains, and calcium channel blockers on retinitis pigmentosa.
    Nakazawa M
    J Ophthalmol; 2011; 2011():292040. PubMed ID: 21253505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene therapy for ocular diseases.
    Liu MM; Tuo J; Chan CC
    Br J Ophthalmol; 2011 May; 95(5):604-12. PubMed ID: 20733027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression characteristics of dual-promoter lentiviral vectors targeting retinal photoreceptors and Müller cells.
    Semple-Rowland SL; Coggin WE; Geesey M; Eccles KS; Abraham L; Pachigar K; Ludlow R; Khani SC; Smith WC
    Mol Vis; 2010 May; 16():916-34. PubMed ID: 20517486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.